Author

Celyne Bueno Hume

Observed names: C. Bueno Hume, C. Hume, Celyne B. Hume, Hume, Celyne Bueno

Institution: The University of Texas MD Anderson Cancer Center

Observed institutions: Mayo Clinic, The University of Texas MD Anderson Cancer Center, Mayo Clinic in Florida, Mayo Clinic Comprehensive Cancer Center (Florida)

ORCID: 0009-0007-4119-6942

Observed ORCID: 0009-0007-4119-6942

OpenAlex ID: A5111607260

Breast Cancer in Latinas: Gene Expression, Differential Response to Treatments, and Differential Toxicities in Latinas Compared with Other Population Groups

2010 · Tejal A. Patel, Gerardo Colon-Otero, et al. · The Oncologist · 46

Brief Report: Comprehensive Clinicogenomic Profiling of Small Cell Transformation From EGFR-Mutant NSCLC Informs Potential Therapeutic Targets

2023 · Bingnan Zhang, Whitney Lewis, et al. · JTO Clinical and Research Reports · 15

Brief Report: Clinical Response, Toxicity, and Resistance Mechanisms to Osimertinib Plus MET Inhibitors in Patients With EGFR-Mutant MET-Amplified NSCLC

2023 · Kaiwen Wang, Robyn Du, et al. · JTO Clinical and Research Reports · 9

Durvalumab-associated generalized morphea with overlapping vitiligo

2022 · Julianna Martel, Woo Cheal Cho, et al. · JAAD Case Reports · 5

1012P Resistance mechanisms to dual EGFR and MET inhibition in patients with EGFR-mutant MET-amplified non-small cell lung cancer

2022 · K. Wang, R. Du, et al. · Annals of Oncology · 4

Real-World Experience of Tarlatamab in Extensive-Stage Small Cell Lung Carcinoma Showed Promising Systemic and Intracranial Efficacy With Higher Neurologic Toxicity

2026 · Mitchell Parma, Kaiwen Wang, et al. · JCO Precision Oncology · 2

Vascular stenting of a malignant arterial blowout as a bridge to effective systemic and regional therapy

2024 · Taylor P. Williams, Mitchell W. Cox, et al. · Journal of Surgical Oncology · 1

Safety and tolerability of lapatinib ditosylate given concurrently with docetaxel, carboplatin, and trastuzumab (TCHL) as part of adjuvant therapy for patients with HER2+ breast cancer: Pilot data from the North Central Cancer Treatment Group Trial N083E.

2010 · C. Bueno Hume, A. Moreno-Aspitia, et al. · Journal of Clinical Oncology · 1

Clinical outcomes of chemotherapy rechallenge in patients with metastatic non-small cell lung (NSCLC) who progressed on immunotherapy maintenance after front line platinum doublets and immunotherapy.

2023 · Kaiwen Wang, Frank V. Fossella, et al. · Journal of Clinical Oncology

A Retrospective Review of Patients with Adenoid Cystic Breast Cancer Treated at Mayo Clinic.

2009 · T. Patel, A. Moreno-Aspitia, et al. · Cancer Research

Works count: 11

Citation count: 82

H-index: 4

I10-index: 2